WPI 3631 (Hydromorphone hydrochloride extended-release 32 mg)
Pill imprint WPI 3631 has been identified as Hydromorphone hydrochloride extended-release 32 mg.
Hydromorphone is used in the treatment of chronic pain; pain; cough; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 32 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 3631
- Strength:
- 32 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Actavis Pharma, Inc.
More about hydromorphone
Consumer resources
- Hydromorphone
- Hydromorphone extended-release capsules
- Hydromorphone high-potency
- Hydromorphone liquid
- Hydromorphone suppository
- More (5) »
- Other brands: Dilaudid, Exalgo, Dilaudid-HP, Palladone
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
